Navigation Links
Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot
Date:4/8/2008

HACKENSACK, N.J., April 8, 2008 /PRNewswire/ -- For a woman facing gynecologic cancer surgery, her best chance for a successful outcome is to choose a gynecologic oncologist, a physician who has undergone extensive training in the surgical treatment of cancers of the female reproductive system. The complexity of the female anatomy and its close proximity to other major organs in the abdomen often means that a cancer that attacks one of the reproductive organs can easily spread to the bladder, colon, or other vital organs. Not only must the malignancy in the reproductive organ be removed, but sections of other major organs may also need to be removed or repaired to give the patient her best chance for survival and preserve her quality of life.

That's why women who are treated for gynecologic cancers at The Cancer Center at Hackensack University Medical Center benefit from the expertise of Daniel H. Smith, M.D., a gynecologic oncologist who is board-certified in obstetrics/gynecology, gynecologic oncology, and general surgery. Dr. Smith is among only a handful of doctors in the world who are board-certified in all of these three specialties. He serves as chief of the Division of Gynecologic Oncology at The Cancer Center.

Dr. Smith's unique background enabled him to envision and then execute further surgical advances by adding another member to his surgical armamentarium -- a daVinci(TM) surgical robot. Used in the past mostly for urologic and cardiac applications, the daVinci(TM) afforded Dr. Smith a new surgical frontier in his quest to make gynecologic cancer surgery easier and safer for patients. Dr. Smith trained extensively on the robot, and then recruited Babak Litkouhi, M.D., a gynecologic oncologist from Ridgewood, NJ, who completed his fellowship at Brigham and Women's Hospital in Boston and who has trained extensively on robotic surgical procedures.

"With our gynecologic oncology team, we have one of the best and most experienced Divisions of Gynecologic Oncology," says Andrew L. Pecora, M.D., chairman and executive administrative director of The Cancer Center at Hackensack University Medical Center. "The Cancer Center has made a major commitment to women with gynecologic malignancies by bringing together Drs. Smith and Litkouhi and supporting their efforts to offer patients innovative and personalized care."

Drs. Smith and Litkouhi use minimally invasive techniques with the laparoscope or the daVinci(TM) robot to treat patients with cervical, endometrial, and early ovarian cancers. Minimally invasive gynecologic surgery with the robot is performed within keyhole abdominal incisions, thus lowering the post-operative risks of pain, wound infections, and difficulties with urinary and respiratory systems. Most patients go home the day after surgery.

"Experience is showing that robotic surgery for gynecologic cancers is at least or more effective than traditional surgery without debilitating side effects," says Dr. Smith, who has been treating gynecologic cancers for almost 30 years. "Robotic surgery can be a good choice for older patients, especially those on multiple medications or anti-coagulants, and obese patients, who were once exempted from some types of laparoscopic gynecologic surgeries."

With five daVinci(TM) robots, Hackensack University Medical Center has the most in the New Jersey and is an East Coast training site for the technology. Surgeons from all over the United States and the world have come to the medical center to learn robotic surgery.

The Cancer Center at Hackensack University Medical Center is New Jersey's largest and the one ranked the best cancer center in the state by New York magazine.


'/>"/>
SOURCE The Cancer Center at Hackensack University Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thomas W. Burke, MD, Elected 40th President of the Society of Gynecologic Oncologists
2. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
3. KGI Elects Three New Members to Board of Trustees
4. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
5. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
6. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
7. BioLife Solutions Expands Scientific Advisory Board
8. NeurogesX Appoints New Director to the Board
9. Genstar Names Michael Hurt to Its Strategic Advisory Board
10. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
11. Bruce Pasternack Elected to Codexis Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... development of a new orally administered treatment for Alzheimer’s disease (AD), today announced ... Didsbury states, “As we seek to uniquely treat the metabolic dysfunctions inherent in ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from non-small cell ... with limited tumor content in a large background of normal or wild type ... need for reliable detection of low abundance somatic mutations, particularly in small specimens ...
(Date:3/27/2017)... ... ... PMG Research is pleased to announce its participation in the 2nd ... Boston on April 3-4, 2017. The CTC conference focuses on how the industry is ... closer to the patient. Clinical Trial Collaborations also will present an inaugural conference on ...
(Date:3/24/2017)... 2017 MiMedx Group, Inc. (NASDAQ: MDXG), the ... tissue allografts and patent-protected processes to develop and market ... announced today  that it will present at the Needham ... NY.  Parker H. "Pete" Petit, Chairman and CEO, ... M. Cashman , EVP and Chief Commercialization Officer, and ...
Breaking Biology Technology:
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/16/2017)... - Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... ...
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
Breaking Biology News(10 mins):